Spencer Brown is a Principal of SG Credit Partners. SG Credit Partners provides $1 to $10 million structured debt solutions to lower middle market businesses nationwide in need of financing for working capital, growth capital, acquisition capital or special situations. Spencer is responsible for originations, deal execution and portfolio management. Prior to working at SG Credit Partners, Spencer was a Vice President at Super G Capital and an Associate at FirstBank Holding Company. Spencer received both a B.A. and an M.B.A. from the University of Colorado at Boulder.

President and Current Chairman of the Board of OPOTEK LLC, Mr. Crozier was the former CEO and principal owner of The Pyrometer Instrument Co., the leading manufacturer of commercial instruments and software for temperature measurement when it was sold in 2015. When he initially acquired Pyrometer in 2002, the business was on the verge of bankruptcy and under his strategic leadership it was swiftly repositioned into a dominant industry performer. Prior to Pyrometer, Mr. Crozier spent 7 years as CEO of Datacolor International, a $75 million revenues industry-leading manufacturer of instruments, software and systems for color management and control. Earlier in his career, Mr. Crozier spent 6 years at Teledyne Industries as President of Teledyne Hastings Instruments and chairman of Teledyne’s Interdivisional Engineering Association. Mr. Crozier holds a BSME degree from the University of Cincinnati and an MBA from John Carroll University.

Dr. Marchand is the COO of Samumed. Founded in 2008, Samumed is a leader in medical research and development for tissue-level regeneration. Samumed develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. Prior to working at Samumed, Dr. Marchand was the CIO of Genoptix (a subsidiary of Novartis) where he initially led engineering development and operations. As CIO, Dr. Marchand oversaw the creation of the Diagnostics Laboratory, the subsequent IPO, and the acquisition of Genoptix by Novartis. Following the acquisition of Genoptix, he assumed responsibilities for global IT operations with Novartis Oncology. Dr. Marchand received a M.S. (Hons.), a Ph.D., and the Research Habilitation in Electrical Engineering from the Université de Haute Alsace, France and was a Lavoisier post-doctoral fellow at the University of California, San Diego.

Larry Simon has over 20 years of Private Equity experience and joined Clearview Capital in 2005. Prior, Larry was with Triton Pacific Capital Partners (Private Equity); Mille Capital (Investment Banking); and The Shattan Group (Investment Banking). Larry received his MBA from Columbia University Graduate School of Business and his Bachelor’s Degree from The Wharton School of the University of Pennsylvania.

Mike Brown serves as outside general counsel for clients, advising them on important business and legal issues. He executes mergers and acquisitions, private equity transactions and venture capital financings, and leads other DLA lawyers in providing legal services to clients in areas outside of his core areas of expertise. Mr. Brown received his B.A from the University of Washington and his J.D. from the University of Virginia. He was has been selected as a member of the San Diego 500 (2016-2019) and as a San Diego Super Lawyer (2018-2019).